Digestive Diseases and Sciences

, Volume 52, Issue 6, pp 1438–1441

Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease

  • Soichi Itaba
  • Tsutomu Iwasa
  • Yojiro Sadamoto
  • Toshifumi Nasu
  • Tadashi Misawa
  • Koji Inoue
  • Hidehiko Shimokawa
  • Kazuhiko Nakamura
  • Ryoichi Takayanagi
CASE REPORT

Keywords

Crohn’s disease Infliximab Pneumocystis jiroveci Pneumocystis pneumonia Corticosteroid 

References

  1. 1.
    Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8:891–890PubMedGoogle Scholar
  2. 2.
    Sepkowiz KA (2002) Opportunistic infestions in patients with and patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34:1098–1107CrossRefGoogle Scholar
  3. 3.
    Roblot F (2005) Management of Pneumocystis pneumonia in patients with inflammatory disorders. Expert Rev Anti Infect Ther 3:435–444PubMedCrossRefGoogle Scholar
  4. 4.
    Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789PubMedCrossRefGoogle Scholar
  5. 5.
    Peters JW, Sattler FR (1983) Atypical Pneumonitis carinii pneumonia: the potential hazards of empric treatment. South Med J 76:800–803PubMedGoogle Scholar
  6. 6.
    Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, Ghrayeb J (1993) Construction and initial characteraization a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443–1453PubMedCrossRefGoogle Scholar
  7. 7.
    Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet 359:1541–1549PubMedCrossRefGoogle Scholar
  8. 8.
    Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462–2476PubMedCrossRefGoogle Scholar
  9. 9.
    Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck SD, Sandborn WJ (2004) The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients. Gastroenterology 126:19–31PubMedCrossRefGoogle Scholar
  10. 10.
    Sandborn WJ, Hanauer SB (2002) Infliximab in the treatment of Crohn’s disease: a user’s guide for clinician’s. Am J Gastroenterol 97:2962–2972PubMedCrossRefGoogle Scholar
  11. 11.
    Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF (2004) Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn’s disease. Inflamm Bowel Dis 10:436–437PubMedCrossRefGoogle Scholar
  12. 12.
    Velayos FS, Sandborn WJ (2004) Pneumocystisis carinii pneumonia during maintenance anti-tumor necrosis factor-a therapy with infliximab for Crohn’s disease. Inflamm Bowel Dis 10:657–660PubMedCrossRefGoogle Scholar
  13. 13.
    Kaur N, Mahl TC (2004) Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn’s disease. Dig Dis Sci 49:1458–1460PubMedCrossRefGoogle Scholar
  14. 14.
    Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S (1996) (1→3)Beta-D-glucan as a quantitive serological marker for Pneumocystis pneumonia. Clin Diagn Lab Immunol 3:197–199PubMedGoogle Scholar
  15. 15.
    Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk. Arch Intern Med 155:1125–1128PubMedCrossRefGoogle Scholar
  16. 16.
    Rizzello F, Gionchetti P, Venturi A, Morselli C, Campieri M (2002) Review article: the management of refractory Crohn’s disease. Aliment Pharmacol Ther 16:40–47PubMedCrossRefGoogle Scholar
  17. 17.
    Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, Meyer zum Buschenfelde KH (1993) Azathioprine combined with predonisolone or monotherapy with prednisolone in active Crohn’s disease. Gastroenterology 105:367–372PubMedGoogle Scholar
  18. 18.
    Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Intern Med 15:132–142Google Scholar
  19. 19.
    Fraser AG, Orchard TR, Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50:485–489PubMedCrossRefGoogle Scholar
  20. 20.
    Khatchatourian M, Seaton TL (1997) An unusual complication of immunosuppressive therapy in inflammatory bowel disease. Am J Gastroenterol 92:1558–1560PubMedGoogle Scholar
  21. 21.
    Cohen RD, Tsang JF, Hanauer SB (2000) Infliximab in Crohn’s disease: first anniversary clinical experience. Am J Gastroenterol 95:3469–3477PubMedCrossRefGoogle Scholar
  22. 22.
    Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, De Bandt M, Dellion S, Rossert J, Rostoker G, Piette JC, Schaeffer A (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246–251PubMedGoogle Scholar
  23. 23.
    Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487–2498PubMedCrossRefGoogle Scholar
  24. 24.
    Wazir JF, Ansari NA (2004) Pneumocystis carinii infection. Update and review. Arch Pathol Lab Med 128:1023–1027PubMedGoogle Scholar
  25. 25.
    Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 337:1029–1035PubMedCrossRefGoogle Scholar
  26. 26.
    Pareja JG, Garland R, Kozeil H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215–1224PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Soichi Itaba
    • 1
  • Tsutomu Iwasa
    • 1
  • Yojiro Sadamoto
    • 1
  • Toshifumi Nasu
    • 1
  • Tadashi Misawa
    • 1
  • Koji Inoue
    • 2
  • Hidehiko Shimokawa
    • 3
  • Kazuhiko Nakamura
    • 4
  • Ryoichi Takayanagi
    • 4
  1. 1.Department of GastroenterologyKitakyushu Municipal Medical CenterKitakyushuJapan
  2. 2.Department of Respiratory MedicineKitakyushu Municipal Medical CenterKitakyushuJapan
  3. 3.Department of Chest SurgeryKitakyushu Municipal Medical CenterKitakyushuJapan
  4. 4.Department of Medicine and Bioregulatory ScienceGraduate School of Medical Sciences, Kyushu UniversityFukuokaJapan

Personalised recommendations